A

Anbio Biotechnology
NASDAQ:NNNN

Watchlist Manager
Anbio Biotechnology
NASDAQ:NNNN
Watchlist
Price: 32.35 USD 6.94% Market Closed
Market Cap: 4.7B USD

Operating Margin
Anbio Biotechnology

24.4%
Current
34%
Average
-4.2%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
24.4%
=
Operating Profit
2m
/
Revenue
8.2m

Operating Margin Across Competitors

No Stocks Found

Anbio Biotechnology
Glance View

Market Cap
4.7B USD
Industry
Biotechnology

Anbio Biotechnology is a DE-based company operating in Biotechnology industry. The company is headquartered in Frankfurt, Hessen. The company went IPO on 2025-02-19. Anbio Biotechnology is a Germany-based company. The firm is primarily engaged in the manufacturing of In Vitro Diagnostic Substance.

NNNN Intrinsic Value
Not Available
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
24.4%
=
Operating Profit
2m
/
Revenue
8.2m
What is the Operating Margin of Anbio Biotechnology?

Based on Anbio Biotechnology's most recent financial statements, the company has Operating Margin of 24.4%.

Back to Top